These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 38364722)

  • 21. Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia.
    Kamal A; Ferguson M; Xavier JC; Liu L; Graham B; Lock K; Buxton JA
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):27. PubMed ID: 37194018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accessing health services through the back door: a qualitative interview study investigating reasons why people participate in health research in Canada.
    Townsend A; Cox SM
    BMC Med Ethics; 2013 Oct; 14():40. PubMed ID: 24119203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia.
    Scow M; McDougall J; Slaunwhite A; Palis H
    Harm Reduct J; 2023 Oct; 20(1):156. PubMed ID: 37875927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "We need to build a better bridge": findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth.
    Marchand K; Fogarty O; Pellatt KM; Vig K; Melnychuk J; Katan C; Khan F; Turuba R; Kongnetiman L; Tallon C; Fairbank J; Mathias S; Barbic S
    Harm Reduct J; 2022 Apr; 19(1):37. PubMed ID: 35430803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
    Comeau E; Bonn M; Wildeman S; Herder M
    PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
    Boyd J; Collins AB; Mayer S; Maher L; Kerr T; McNeil R
    Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada.
    Bardwell G; Ivsins A; Socías ME; Kerr T
    J Subst Abuse Treat; 2021 Nov; 130():108418. PubMed ID: 34118706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
    Nguyen HV; Mital S; Bugden S; McGinty EE
    JAMA Intern Med; 2024 Mar; 184(3):256-264. PubMed ID: 38227344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Privacy Perspectives on Health Information Exchange in a Mental Health Context: Qualitative Study.
    Shen N; Sequeira L; Silver MP; Carter-Langford A; Strauss J; Wiljer D
    JMIR Ment Health; 2019 Nov; 6(11):e13306. PubMed ID: 31719029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of mindfulness based programs in reducing stress experienced by nurses in adult hospital settings: a systematic review of quantitative evidence protocol.
    Botha E; Gwin T; Purpora C
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):21-9. PubMed ID: 26571279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution to Detect, Classify, and Report Illicit Online Marketing and Sales of Controlled Substances via Twitter: Using Machine Learning and Web Forensics to Combat Digital Opioid Access.
    Mackey T; Kalyanam J; Klugman J; Kuzmenko E; Gupta R
    J Med Internet Res; 2018 Apr; 20(4):e10029. PubMed ID: 29613851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and outcomes of paid undergraduate student nurse positions.
    Gamroth L; Budgen C; Lougheed M
    Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
    Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
    Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.
    Kuo M; Shamsian A; Tzemis D; Buxton JA
    Harm Reduct J; 2014 Apr; 11():13. PubMed ID: 24766846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "There's absolutely no downside to this, I mean, except community opposition:" A qualitative study of the acceptability of vending machines for harm reduction.
    Stewart RE; Cardamone NC; Loscalzo E; French R; Lovelace C; Mowenn WK; Tarhini A; Lalley-Chareczko L; Brady KA; Mandell DS
    Harm Reduct J; 2023 Feb; 20(1):25. PubMed ID: 36855064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.